ACM
ELV icon

Aljian Capital Management’s Elevance Health ELV Stock Holding History

Aljian Capital Management’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$802K Buy
2,074
+8
+0.4% +$2.97K 0.15% 70
2026
Q1 		$605K Sell
2,066
-71
-3% -$23.3K 0.12% 79
2025
Q4 		$749K Sell
2,137
-142
-6% -$48K 0.15% 67
2025
Q3 		$736K Sell
2,279
-46
-2% -$14.3K 0.15% 73
2025
Q2 		$904K Sell
2,325
-97
-4% -$39K 0.2% 61
2025
Q1 		$1.05M Buy
2,422
+7
+0.3% +$2.81K 0.25% 52
2024
Q4 		$891K Buy
2,415
+8
+0.3% +$3.35K 0.19% 55
2024
Q3 		$1.25M Buy
+2,407
New +$1.29M 0.29% 42

Other funds holding ELV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Aljian Capital Management's ELV Position: Q2 2026 in Review

Aljian Capital Management increased its Elevance Health (ELV) stake by 0.39% in Q2 2026, buying an estimated $2.97K and bringing the position to 2,074 shares worth $802K. The position accounts for 0.15% of the portfolio, ranked #70.

Aljian Capital Management first reported a position in ELV in Q3 2024 and has held it in 8 quarters since. The position peaked at $1.25M in Q3 2024. 1,607 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Aljian Capital Management held 2,074 shares of Elevance Health worth $802K as of Q2 2026.
  • Aljian Capital Management bought 8 Elevance Health shares in Q2 2026, an estimated $2.97K.
  • Elevance Health made up 0.15% of Aljian Capital Management's portfolio in Q2 2026, its #70 holding.
  • Aljian Capital Management first reported a position in Elevance Health in Q3 2024 and has held it in 8 quarters since.
  • Aljian Capital Management's Elevance Health position peaked at $1.25M in Q3 2024.
  • 1,607 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Aljian Capital Management's 13F filing for Q2 2026, filed 7 Aug 2026.